Clinical Trial Update: A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children [Phase 3]

View source ↗

Summary

A Phase III clinical trial is evaluating deuremidevir hydrobromide for treating respiratory syncytial virus infection in infants and young children, and the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Deuremidevir hydrobromide (Deuremidevir hydrobromide)

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Respiratory Syncytial Virus Infection | Phase 3 | Status: RECRUITING